英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Taffel查看　Taffel　在百度字典中的解释百度英翻中〔查看〕
Taffel查看　Taffel　在Google字典中的解释Google英翻中〔查看〕
Taffel查看　Taffel　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • KYMRIAH® (tisagenlecleucel) | Official Patient Website
    KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that is either relapsing (went into remission, then came back) or is refractory (did not go into remission after receiving other leukemia treatments)
  • Kymriah: Uses, Dosage, Side Effects Warnings - Drugs. com
    Kymriah (tisagenlecleucel) is an expensive CAR-T cell cancer therapy costs over $612,000 for one treatment infusion, but most people do not pay this amount In addition, the Centers for Medicare Medicaid Services (CMS) states that CAR-T cell therapy would be covered for eligible people with Medicare
  • Kymriah™ (tisagenlecleucel) - Roswell Park Comprehensive Cancer Center
    Kymriah is an FDA-approved immunotherapy — a treatment designed to help your own immune system fight cancer Specifically, it is a type of chimeric antigen receptor (CAR) T-cell therapy It strengthens and multiplies your T cells, the special white blood cells in your body that have the power to destroy cancer cells
  • Kymriah® (tisagenlecleucel) – An overview of the clinical development . . .
    ABSTRACT The emergence of cell and gene therapies has dramatically changed the treatment paradigm in oncology and other therapeutic areas Kymriah® (tisagenlecleucel), a CD19-directed genetically modified autologous T-cell immunotherapy, is currently approved in major markets for the treatment of relapsed refractory (r r) pediatric and young adult acute lymphoblastic leukemia, r r diffuse
  • Tisagenlecleucel - NCI - National Cancer Institute
    Use in Cancer Tisagenlecleucel is approved to treat: B-cell acute lymphoblastic leukemia It is used in children and adults up to 25 years old whose cancer does not respond to treatment or has relapsed two or more times; B-cell non-Hodgkin lymphoma (NHL), including the following types: diffuse large B-cell lymphoma (DLBCL)
  • Kymriah: Cost, Uses, Dosage, and More - Healthline
    Kymriah is used to treat certain kinds of cancer that have relapsed (come back) or are refractory (didn’t respond or stopped responding to other treatments) Specifically, Kymriah can be used in:
  • KYMRIAH Treatment Process, Dosing Administration | HCP
    MORE THAN 5000 CLINICAL AND COMMERCIAL PATIENTS HAVE RECEIVED KYMRIAH 3 As soon as you have identified a patient who may be a candidate for KYMRIAH, contact a treatment center to discuss eligibility, current treatments, and next steps, as ongoing chemotherapy can lead to T cell depletion, 4 which may affect the quality of the final cell product
  • How Does Kymriah Treat Leukemia and Lymphoma? - GoodRx
    This means that 81% of people who received Kymriah saw a disappearance of all signs of their cancer, or experienced a decrease in the amount of cancer in their body Kymriah was also studied as a treatment for adults with relapsed or refractory DLBCL Of the 93 adults that received Kymriah, 40% had a complete response This means that 40% of
  • An introduction to T KYMRIAH THERAPY - Texas Children’s
    in different types of treatment options, including KYMRIAH® (tisagenlecleucel) KYMRIAH is a type of cutting-edge immunotherapy that uses the power of your own immune system to treat your cancer KYMRIAH is not a pill, chemotherapy, or stem cell transplant It is a type of treatment called CAR-T The CAR in CAR-T stands for chimeric antigen
  • Understanding Kymriah: The Future of Biologic Drugs in Cancer Treatment
    Kymriah, the first FDA-approved CAR T-cell therapy, has significantly transformed cancer treatment, particularly for blood cancers like pediatric acute lymphoblastic leukemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) This innovative therapy involves collecting and genetically modifying a patient’s T cells to target CD19, a protein on B cells, resulting in complete remission





中文字典-英文字典  2005-2009